AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2009
Dec 3, 2009
34519_dirs_2009-12-03_79c1d629-aa37-45c9-baf8-98b18b0484bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-12-01
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-12-01 | Common Stock, par value $0.10 per share | P | 1300 | $3.90 | Acquired | 454616 | Direct |
| 2009-12-01 | Common Stock, par value $0.10 per share | P | 265 | $3.97 | Acquired | 454881 | Direct |
| 2009-12-01 | Common Stock, par value $0.10 per share | P | 200 | $3.90 | Acquired | 455081 | Direct |
Footnotes
F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
F2: This figure includes 189,537 of common stock, held by Arterio, Inc., a company owned solely by Jonathan Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23